Cells become cancerous when they loose their ability to undergo programmed cell death (known as “apoptosis”). Until recently, apoptosis [MORE]
In 1955, the National Cancer Institute began organizing oncologists into regional study groups to address specific interests that NCI [MORE]
Getting the right mix of chemotherapy drugs, properly diluted, in a sterile IV bag, without contamination, can be a [MORE]
Imagine the sign on the door: “California NanoSystems Institute: Nano Machine Center for Targeted Delivery and On-Demand Release.” [MORE]
A research group at the University of North Carolina-Chapel Hill recently presented their technology for delivering anticancer [MORE]
Protein scientists in Germany and Japan have developed a new biochip that can detect proteins for specific diseases and [MORE]
As an indication of things to come, Qiagen (Venlo, The Netherlands) signed an exclusive agreement with Johns Hopkins [MORE]
Swiss diagnostic and therapeutic giant, Roche, recently invested more than $181m in Halozyme Therapeutics (San Diego, CA) to develop a [MORE]
Angle-resolved low coherence interferometry (a/LCI) is a technology that allows oncologists to determine how effectively an anticancer drug is working. [MORE]